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Bioﬁlm formationCandidiasis is often observed in immunocompromised patients and is the 4th most common cause of
bloodstream infections. However, antifungals are limited, so novel antifungal agents are urgently needed.
Antimicrobial peptides (AMPs) are considered as potential alternatives of conventional antibiotics. In the present
study, antimicrobial peptide protonectin was chemically synthesized and its antifungal activity and mode of
action were studied. Our results showed that protonectin has potent antifungal activity and fungicidal activity
against the tested fungi cells. Its actionmode involved the disruption of themembrane integrity and the inducing
of the production of cellular ROS. Furthermore, protonectin could inhibit the formation of bioﬁlm and kill the
adherent fungi cells. In conclusion, with the increase of fungal infection, protonectin may offer a new strategy
and be considered as a potential therapeutic agent against fungal disease.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Candida is a causal trigger of opportunistic oral and genital infections
that frequently coexists in the human oral cavity and gastrointestinal
tract. In general, Candida is innocuous although overgrowth of Candida
results in candidiasis. Candidiasis is often observed in immunocompro-
mised patients (e.g., AIDS) and is the 4thmost common cause of blood-
stream infections, with an estimated mortality rate upwards of 25% [1].
However, treatment against Candida infections involving triazoles (i.e.
ﬂuconazole and itraconazole) is often inoperative because Candida
cells could acquire resistance after long periods of treatment, leading
to higher susceptibility to fungal infections [2]. The severe adverse
effects of antifungals like liver damage, allergic reactions or disorder of
estrogen levels also made the traditional antifungals have limited clini-
cal application [3]. In addition, the formation of highly drug-tolerant
bioﬁlm by Candida cells further exacerbates the antifungal therapeutic
challenge [4,5]. So a novel strategy is eagerly needed for the control of
fungal infections
It is believed that antimicrobial peptides could be potential alter-
natives of conventional antifungals [6]. AMPs are an evolutionarily con-
served component of the innate immunity and exist among all classes of
life, ranging from prokaryotes to plants, insects, amphibians and mam-
mals [7–11]. They have a broad spectrum of antimicrobial activitiesSciences, Lanzhou University,
rui@lzu.edu.cn (R. Wang).against bacteria,mycobacteria, enveloped viruses, fungi and even trans-
formed or cancerous cells. So far, lots of AMPs demonstrating antifungal
activities have been isolated and characterized. The antifungal action
modes of AMPs are diverse, including disrupting fungal cell membrane
and inhibiting intracellular targets. So it is believed that the possibility
for fungal cells to develop resistance toward AMPs is relatively low [12].
Protonectin was originally isolated from the venom of the neotropi-
cal social wasp Agelaia pallipes pallipes, with an amino acid sequence of
ILGTILGLLKGL-NH2 (1210.57 Da) [13]. It has potent antimicrobial activ-
ity against both gram positive and negative bacteria, but weak hemolyt-
ic activity [13,14]. However, the effect of protonectin on fungi cells has
not been reported. In this study, protonectin was chemically synthe-
sized and antifungal activity against Candida cells was determined.
Then, the effects of protonectin on the integrity of fungal cell membrane
and some intracellular events were investigated. Our results showed
that protonectin had potent antifungal activity against Candida cells
and the action mode involved membrane disturbance and the inducing
of ROS production.
2. Material and methods
2.1. Peptide synthesis
Protonectin (ILGTILGLLKGL-NH2) was synthesized by a step-
wise solid-phase method on rink amide MBHA resin using N-9-
ﬂuorenylmethoxycarbonyl (F-moc) chemistry [15]. After cleavage,
protonectin was desalted using a Sephadex gel column and puriﬁed
by reverse-phase high-performance liquid chromatography (RP-HPLC,
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ent elution of 20% to 80% CH3CN/H2O with 0.1% triﬂuoroacetic acid
(TFA) at a ﬂow rate of 8 ml/min. The atomic mass of the synthetic pep-
tide was conﬁrmed by electrospray ionization-mass spectrometry (ESI-
MS, MaXis 4G, Bruker, Germany). Antimicrobial peptides melittin and
magainin-2 also were synthesized and puriﬁed. The peptide was dis-
solved in double-distilled water and stored at−20 °C before use.
2.2. Fungi and materials
Candida albicans (ATCC 14053), Candida glabrata (ATCC 2001),
Candida parapsilosis (ATCC 22019), Candida tropicalis (ATCC 750), and
Candida krusei (ATCC 6258) used in this study were purchased from
the American Type Culture Collection (ATCC) and the C. glabrata 14-1,
C. albicans 14-2, C. albicans 14-3, and C. albicans 1-4 were clinically iso-
lated. Dry powder of Candida strainswas dissolved in sterile phosphate-
buffer solution (PBS), shaken and spread on Sabouraud dextrose broth
plate. After overnight incubation at 35 °C, a colony was cultured into
Sabouraud dextrose broth medium at 35 °C for 12 h with shaking to
get logarithmic phase. The fresh culture was centrifuged, washed and
re-suspended in 25% C3H8O3/H2O and stored at −80 °C before use.
Agents used for peptide synthesis were purchased from GL Biochem
Ltd (Shanghai, China) with desired purity.
2.3. Antifungal assays
2.3.1. The minimum inhibition concentration assay (MIC)
The antifungal assay was determined according to the EUCAST
method with minor modiﬁcations [16]. Brieﬂy, cells activated in
Sabouraud dextrose broth medium were washed, diluted and inoculat-
ed into 96 well ﬂat-bottom plates containing serially two fold dilutions
of protonectin. The plates with an inoculum size of 0.5 × 105 to
2 × 105 CFU were statically placed in an incubator at 35 °C overnight.
Minimal inhibitory concentration (MIC) of protonectin was deﬁned as
the lowest concentration at which no visible turbidity was observed
compared with drug-free group. The MICs assay was repeated in
triplicate.
2.3.2. The minimum fungicidal concentration assay (MFC)
For minimal fungicidal concentration (MFC) determination, 50 μl
cultures at concentration equal to or above MIC were plated on
Sabouraud dextrose broth plate for CFU counting. After incubation at
35 °C for 24 h, theMFCwas deﬁned as the lowest concentration that re-
sulted in 99.9% killing compared to drug-free group. TheMFC assay was
repeated in triplicate.
2.3.3. Radial diffusion assay
The fungicidal activity of protonectin was evaluated by a modiﬁca-
tion of the sensitive radial diffusion assay. Brieﬂy, the fungi cells were
cultured as described above. One milliliter of the fungi 107 CFU was
added to 100 ml of previously autoclaved, warm Sabouraud dextrose
agar. After rapid dispersion of the fungi, the agar was poured into anTable 1
MIC values of protonectin against the tested Candida cells.
MIC (μM &μg/ml)b
Peptide C. glabrata
ATCC 2001
C. albicans
ATCC 14053
C. parapsilosis
ATCC 22019
C.tropicalis
ATCC 750
Protonectina 32/38.8c 32/38.8c 128/155c 8/9.7c
Melittin 32/91c 4/11.4 c 64/182 c 1/2.8 c
Magainin2 32/79c 32/79c 128/315.8 c 16/39.5 c
a Initially obtained byMaria AnitaMendes et al. The sequence is ILGTILGLLKGL-amide. The cal
value (Mobs) is 1211.3. Mobs was deduced from the protonated molecule (M+ H+).
b Both the values in μM &μg/ml were provided.
c The left of diagonal mark (/) is the MIC value in μM, while the right is the MIC value in μg/agar plate to form a layer approximately 5 mm deep and was punched
with a 3-mm-diameter gel punch to make evenly spaced wells. Follow-
ing the addition of 25 μl with different concentrations of protonectin to
eachwell, the plates were incubated at 35 °C for 18 to 24 h. 25 μl of ster-
ile water was added as a control.
2.3.4. Time-killing kinetics of protonectin against Candida cells
Time-killing kinetics of protonectin against Candida cells were per-
formed according to standard microbiological techniques with minor
modiﬁcations [17]. Logarithmic cultures diluted to an inoculum size of
104–105 CFU in fresh Sabouraud dextrose broth mediumwere incubat-
ed with protonectin at the required concentration, and themixture was
incubated at 35 °C with shake. To determine the viabilities of the cul-
tures, the cells were then taken and serially diluted at different intervals
after treatment and plated on Sabouraud's dextrose agar plates of 9 cm
in diameter for CFU counting. The original number of colonies was con-
ﬁrmed at time zero. The killing activity of protonectin was illustrated by
plotting the log10 CFU per milliliter against incubation time. Sabouraud
dextrose broth medium was run as negative control.
2.4. Protonectin binding assay with Candida cells
Binding of protonectin to the surface of Candida cells was examined
by assessing the effect of representative fungal cell wall polysaccharides
on killing activity of protonectin described before [18]. In brief,
protonectin (ﬁnal concentration, 256 μM) reacted with increasing con-
centration of each representative cell wall polysaccharide at 35 °C for
1 h. After incubation, 100 μl of samples was collected directly into
tubes containing an equal volume of Candida cultures with an inoculum
size of 2 × 105 CFU for 1 h and serially diluted in Sabouraud dextrose
brothmedium. Aliquots of 100 μl were spread onto Sabouraud dextrose
broth agar plates and incubated for 48 h at 35 °C. The killing rate % =
100 × (1 − Ft / Fo), in which Fo and Ft represented the CFU of
polysaccharide-free group and polysaccharide-treated group. Theﬁgure
was plotted as killing rate against polysaccharide concentration.
2.5. Localization of FITC-protonectin (FITC-pro) in Candida cells
2.5.1. Confocal laser scanning microscopy
C. glabrata cell cultures at logarithmic phasewith an inoculum size of
106–107 CFUwere exposed to 64 μM in Sabouraud dextrose brothmedi-
um for timed duration at 35 °C. Microscopic analysis was done with a
laser confocal scanning microscope (Zeiss LSM 710 META) after
60 min incubation.
2.5.2. Flow cytometric analysis
For FACS assay, C. glabratacell cultures with an inoculum size of 106–
107 CFUwere exposed to FITC-pro in Sabouraud dextrose brothmedium
at different concentrations for 2 h at 35 °C with shaking. After incuba-
tion, the cells were centrifuged, washed and resuspended with PBS.
Flow cytometric analysis was conducted by a FACS Calibur ﬂow
cytometer (Becton–Dickinson, San Jose, CA, USA).C. krusei
ATCC 6258
C. glabrata
14-1
C. albicans
14-2
C. albicans
14-3
C. albicans
14-4
32/38.8c 32/38.8c 32/38.8c 32/38.8c 32/38.8c
16/45.5 c 32/91 c 8/22.8 c 32/91 c 16/45.5 c
16/39.5 c 32/79 c 32/79 c 64/158 c 64/158 c
culatedmonoisotopicmass value (Mcalc)is 1210.57,while the observedmonoisotopicmass
ml.
Fig. 1. The fungicidal activity of protonectin (0, 200, 300, 400, 500, 600, and 700 μM) against C. tropicalis ATCC 750 (A), C. albicans ATCC 14053 (B), C. glabrata ATCC 2001 (C) and C. krusei
ATCC 6258 (D) was determined by radial diffusion assay. Protonectin made fungi-free zones around the wells in a concentration dependent manner. (The diameter of wells was 3 mm).
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2.6.1. Confocal laser scanning microscopy
The propensity of protonectin to cause loss of membrane integrity
wasmeasured by PI uptake assay using a laser confocal scanningmicro-
scope and FACS. Brieﬂy, freshly collected logarithmic C. glabrata (ATCC
2001) cultures with an inoculum size of 106–107 CFU were incubated
with protonectin at 128 μM (4 × MIC) or PBS as negative control. After
incubation at 35 °C for 60 min, PI solution was added to get a ﬁnal con-
centration of 50 μg/ml and a further incubation was conducted for
15 min. At the end of incubation time, cells were centrifuged, washed
and re-suspended with phosphate-buffer solution (PBS) and micro-
scopic analysis was done with a laser confocal scanning microscope
(Zeiss LSM 710 META).2.6.2. Flow cytometry analysis
To quantitatively analyze the loss of fungal membrane integrity after
peptide treatment, C. glabrata cells (106–107 CFU) were treated with an
increasing concentration of protonectin, and incubated for 2 h at 35 °C.
After incubation, the cells were stained with PI (ﬁnal concentration =Table 2
MFC values of protonectin against the tested Candida cells.
MFC (μM &μg/ml)a
Peptide C. glabrata
ATCC 2001
C. albicans
ATCC 14053
C. parapsilosis
ATCC 22019
C.tropicalis
ATCC 750
Protonectin 64/77.5b 128/155b 256/310b 16/19.9b
Melittin 64/182 b 32/91 b 64/182 b 2/5.7 b
Magainin2 32/79 b 64/158 b N128/315.8 b 32/79 b
a Both the values in μM &μg/ml were provided.
b The left of diagonal mark (/) is the MIC value in μM, while the right is the MIC value in μg/50 μg/ml) and incubated for 15 min at room temperature in dark
place. Subsequently, the cells were harvested by centrifugation,
washed and suspended in PBS. Flow cytometric analysis was con-
ducted by a FACS Calibur ﬂow cytometer (Becton–Dickinson, San
Jose, CA, USA).2.7. Electron microscopy
To view the morphological change of fungal cells after treatment
with protonectin, electron microscopy was employed [19]. In brief,
C. glabrata cells grown to logarithmic phase with an inoculum size of
106–107 CFU were incubated with protonectin at the concentration of
125 μM or Sabouraud dextrose broth medium as negative control.
After incubation for 2 h at 35 °Cwith shaking, the cells were centrifuged,
washed twice with PBS, re-suspended and ﬁxed with an equal volume
of 5% (v/v) glutaraldehyde in 0.2 M sodium cacodylate buffer at 4 °C
overnight. The pellet was re-suspended. A drop containing treated
C. glabrata cells was deposited onto a carbon-coated grid and negatively
stained with 1% (wt/v) uranyl acetate. The grids were examined by
using a scanning electron microscope (JSM-6380Lv, Japan).C. krusei
ATCC 6258
C. glabrata
14-1
C. albicans
14-2
C. albicans
14-3
C. albicans
14-4
32/38.8b 32/38.8b 64/77.5b 64/77.5b 32/38.8b
32/91 b 32/91 b 32/91 b 64/182 b 32/91 b
16/39.5 b 32/79 b 32/79 b 64/158 b 64/158 b
ml.
Fig. 2. Time-killing kinetics of protonectin against the testedCandida cells: (A), C. glabrata (ATCC 2001); (B), C. albicans (ATCC14053); (C), C. parapsilosis (ATCC22019); (D), C. krusei (ATCC
6258) and (E), C.tropicalis (ATCC 750). Cells were cultured in the presence of protonectin at indicated concentrations or Sabouraud's dextrose broth (0 μMprotonectin) as negative control
with shaking. The residual viable cells were monitored as the numbers of CFU on Sabouraud's dextrose agar plates of 5 cm in diameter at different intervals after treatment. Error bars
represent standard error from mean cell proliferation as determined by repeated experiments.
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Endogenous amounts of ROS were measured by ﬂuorometric
assay with 2′,7′-dichloroﬂuorescin diacetate (DCFH-DA) as de-
scribed earlier [20]. Brieﬂy, the logarithmic C. glabrata cells were
centrifuged, washed and re-suspended in PBS to an OD600 of 1. The
cultures were then treated with protonectin alone or in combination
with ascorbic acid or left untreated for 1 h at 35 °C. After incubation,
10 μM 2′,7′-dichloroﬂuorescin diacetate in PBS was added. TheFig. 3. Effect of representative Candida cell wall polysaccharides (laminarin (β-1,3-glucan) an
mannans were pre-incubated with protonectin for 1 h, then incubated with Candida cells (left
as the negative control. The binding effects of protonectin with cell wall polysaccharides were
mean cell proliferation as determined by repeated experiments.ﬂuorescence intensities (excitation 488 nm and emission 525 nm re-
spectively) of the treated cells were measured with a spectroﬂuo-
rometer at different intervals.
2.9. Bioﬁlm killing test
The bioﬁlm was prepared according to the previous method with
minor modiﬁcations [21]. Brieﬂy, the logarithmic C. glabrata cultures
grown in Sabouraud dextrose broth for 18 h at 35 °C in a rotary shakerd mannans) on the killing rate of protonectin against tested Candida cells. Laminarin and
panel: C. albicans; right panel: C. glabrata) for another 1 h. Laminarin and mannans served
reﬂected by the reduction of fungicidal activity. Error bars represent standard error from
Fig. 4. Cellular localization of protonectin in C. glabrata cells. The confocal micrographs of C. glabrata cells treated with FITC-pro. (A) Fluorescence microscopy; (B) DIC microscopy;
(C) merged pictures. Bars, 1 μm.
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hemacytometer and inoculated into polystyrene 96-well microplates
with an inoculum size of 1 × 106 to 2 × 106 CFU. The plates were incu-
bated at 35 °C with 120 rpm shaking to provide shear forces. Bioﬁlms
were formed over a series of time intervals to get adhesion-stage
bioﬁlms (1 h), early-stage bioﬁlms (5 h) and mature-stage bioﬁlms
(18 h). At the end of incubation time, the wells containing C. glabrata
bioﬁlms were washed with PBS twice to remove non-adhered
C. glabrata cells and exposed to different concentrations of protonectin
or Sabouraud dextrose broth as negative control. After incubation at
35 °C for 24 h, the cells were washed three times with 0.05% Tween
20 in Tris-buffered saline (TBS). Bioﬁlm formation was evaluated by
observation in an inverted microscope.
3. Results
3.1. Protonectin showed potent antifungal activity against Candida cells
In this study, protonectin was chemically synthesized by a stepwise
solid-phase chemosynthesis assay and its antifungal activity was in-
vestigated. As shown in Table 1, protonectin showed potent antifungal
activity against C. glabrata, C. albicans, C. parapsilosis, C.tropicalis, and
C. kruseiwith theMICs of 32 μM, 32 μM, 128 μM, 8 μMand 32 μMrespec-
tively. The fungicidal activity also was determined. As shown in Fig. 1,
protonectin exhibited its fungicidal activity in a dose dependent man-
ner. The MFCs of protonectin against the tested Candidian cells were
shown in Table 2, which were 2–4 times of their MICs. The time-killing
kinetics also was carried out to evaluate their fungicidal activity againstFig. 5. Flow cytometric analysis of FITC-pro staining in C. glabrata cells. Cells showed an
increased ﬂuorescent intensity. C. glabrata cells treated with FITC-pro (16 μM, 32 μM,
64 μMand 128 μM) for 2 h at 37 °C. Then cells were washed three times in 10mM sodium
phosphate buffer (pH 7.4) and determined by FACS.time. Our results showed that at the concentration of 2 × MIC or
4 × MIC, protonectin could reduce inoculum by 100% within 12 h,
while at the concentration of MIC, it exhibited fungistatic activity
(Fig. 2).
3.2. Protonectin could speciﬁcally bind with β-1,3-glucan
As we know, fungal species has cell wall to protect the cell against
harsh extracellular environment [22]. However, the role of fungal cell
wall in the process of peptide–cell interaction is unintelligible. So in
the present study, in order to investigate whether protonectin could
bind with fungal cell surface, the interaction of protonectin with the
main component of cell wall was determined. Protonectin at the con-
centration of 256 μM was incubated with different concentrations of
the polysaccharides laminarin and mannans. Then, the fungicidal activ-
ity of the mixture was tested. As shown in Fig. 3, pre-incubation of
protonectin with laminarin at high concentration of 12.5 or 25 mg/ml
for 1 h decreased the killing activity dramatically, while mannans have
a little effect on the fungicidal activity of protonectin. It revealed that
the relative speciﬁcity of binding between protonectin and laminarin
played a crucial role in the binding of protonectin with Candida cells.
3.3. Protonectin could accumulate on the fungal cell surface
As protonectin could speciﬁcally bind toβ-1, 3-glucan, a polysaccha-
ride representative of fungal cell wall that is abundant in fungal cell
wall, FITC-pro was used to reveal the interaction between protonectin
and Candida cells. As shown in Fig. 4, FITC-pro was attached to the sur-
face of C. glabrata cells. The accumulation on the surface was ensued by
the inﬂux of protonectin into cytoplasm. As shown in Fig. 5, the increase
of ﬂuorescence intensity caused by increasing concentration of
protonectin indicated that the interaction between protonectin and
C. glabrata cells was in a dose-dependent manner, as monitored by
FACS. Contrastively, the accumulation could be detained by the pre-
incubation of FITC-pro and β-1, 3-glucan (Fig. S1).
3.4. Protonectin could cause the loss of cell integrity
In the present study, the effect of protonectin on the integrity of the
fungal cell membrane was determined by PI uptake assay. PI is mem-
brane impermeable and generally excluded from viable cells. When
the membrane integrity lost, PI could pass through plasma membrane
and bind with genomic DNA and give a red ﬂuorescence with the exci-
tation of 480 nm laser. As shown in Fig. 6 under the view of a confocal
ﬂuorescence microscope, C. glabrata cells treated by protonectin
showed red ﬂuorescence while the untreated group showed no ﬂuores-
cence. This indicated that protonectin could disturb the integrity of the
tested fungal cells. Then the FACS assay was employed to verify the up-
take of PI. As shown in Fig. 7, protonectin could induce the shift of
Fig. 6.Microscopy analysis of membrane permeabilization detected by propidium iodide uptake assay in C. glabrata cells after incubation with 0uM peptides (A–C) and 128 μM peptides
(D–E) for 1 h at 35 °C.
2370 K. Wang et al. / Biochimica et Biophysica Acta 1848 (2015) 2365–2373ﬂuorescence intensity in a dose dependent manner. This result was
consistent with the confocal microscopy assay.3.5. Protonectin caused morphological change of Candida cells
In this study, scanning electron microscopy was employed to deter-
mine the effect of protonectin on the morphology of the fungal cells. As
shown in Fig. 8, C. glabrata cells treated by protonectin showed an
anomalous morphological structure with inﬂated, uneven and discrete
cell wall. The cells were surrounded by numerous vesicular structures.
However, in the control group, the untreated cells have continuous,
smooth and intact cell wall with little vesicular structure.Fig. 7. Cytometric analysis of membrane permeabilization. C. glabrata cells treated with
protonectin, exhibit increased PI uptake. C. glabrata cells were incubated for 2 h at 37 °C
with protonectin (16 μM, 32 μM, 64 μM and 128 μM), followed by a 30 min incubation
with 50 mg/ml PI. Cells were washed three times in 10 mM sodium phosphate buffer
(pH 7.4) and analyzed by FACS.3.6. Protonectin could induce ROS production in a time- and
dose-dependent manner
In the present study, DCFH-DA was employed to monitor the pro-
duction of ROS in the Candida cells after treatment by protonectin. The
cell-permeant dye DCFH-DA is oxidized to yield the ﬂuorescent mole-
cule 2′,7′-dichloroﬂuorescein, which can be monitored by a FlexStation
3 benchtop multi-mode microplate reader (FlexStationIII) with the
maximum excitation wavelength of 488 nm and the maximum emis-
sion wavelength of 525 nm. Compared with the control cells, pro-
tonectin induced a rapid increase in ﬂuorescence in a dose- and time-
dependent manner. No ﬂuorescence increase was detected when the
cells were treated with protonectin in combination with a well-known
antioxidant ascorbic acid (Fig. 9).
3.7. Protonectin demonstrated antifungal activity against adhered
fungal cells
Bioﬁlms were dynamic communities of microorganisms tenaciously
attached to biological and nonbiological surfaces and were enclosed in
self-producedmatrix to allow fungal cells survive in harsh environment
and disperse to colonize new foothold [23]. The kinetics of bioﬁlm for-
mation revealed that there were three phases, including adhesion
phase (1–3 h), intermediate phase (4–8 h) and maturation phase
(18–36 h) when planktonic cells were cultivated into wells of polysty-
rene 96-well plates. At adhesion phase, the cells adhere to the bottom
of the wells in a monolayer cell manner and undergo a morphological
change from yeast like phenotype to ﬁlamentous type. With a further
incubation for 4 h, the cells multiply and group in clusters in a ﬁlamen-
tous form. At maturation phase, adherent cells are embedded within a
self-producedmatrix generally composed of extracellular DNA, proteins
and polysaccharides. At this point, the bioﬁlm always were consisted of
several layers of cells [21]. Our results showed that protonectin could
inhibit the growth of adhesion-stage or intermediate-stage bio-
ﬁlm completely at the concentration of 1–2 × MIC. While at the
Fig. 8. Scanning electron microscopy of protonectin treated C. glabrata cells. Mid-growth-phase C. glabrata were incubated with protonectin (at the concentration of 2 × MIC) for 4 h at
room temperature. The surface of untreated C. glabrata cells was smooth (A) and the surfaces of the protonectin-treated cells were rufﬂed, and became disrupted (B).
2371K. Wang et al. / Biochimica et Biophysica Acta 1848 (2015) 2365–2373concentration belowMIC, the growth of bioﬁlm was partially inhibited.
For the maturation phase bioﬁlm, protonectin had a weaker inhibition
effect. The inhibition concentration was up to 4 × MIC (Fig. 10).
4. Discussion
The increasing multidrug resistance of microorganisms to available
traditional antibiotics and antifungal agents is becoming a global puzzle,
resulting in enormous efforts to develop new antibiotics and antifungal
agents withmore effective efﬁcacy. One of the promising alternatives of
traditional agents is host-defense cationic antimicrobial peptides. AMPs
are an integral component of the innate immune system of all biological
organisms, functioning in themode of physically permeating and rapid-
ly disrupting themicroorganism cell membrane. Therefore, the possibil-
ity of microbial resistance toward AMPs is limited. Based on these
properties, AMPs attracted more and more attention.
In the present study, we investigated the antifungal activity of
cationic antimicrobial peptide protonectin. Our results showed that
protonectin had a potent antifungal activity against C. albicans and
C. glabrata. As our previous study reported, membrane active action
mode was involved in the mechanism of protonectin against bacteria.
So the effect of protonectin on the integrity of fungal cell membraneFig. 9. Effect of protonectin on the cellular ROS formation of C. glabrata cells. The C. glabrata
cells were incubated in the presence of protonectin at indicated concentration, or in
the presence of the combination of protonectin and ascorbic acid for 1 h at 35 °C, then
10 μM 2′,7′-dichloroﬂuorescin diacetate (ROS-sensitive probe) was added. The
ﬂuorescence was monitored at different intervals. Error bars represent standard error
from mean cell proliferation as determined by repeated experiments.also was determined in this study. Our results from PI uptake assay
and SEM assay showed that protonectin also could disrupt the integrity
of the fungal cell membrane. However, as we know, fungal cells have a
polysaccharide cell wall as a boundary to protect them from the harsh
environment. Accounting for 80–90% of the cell wall of Candida is con-
stituted by carbohydrate that envelops cells with an elastic and multi-
functional barrier and maintains structural integrity [22]. In Candida
cells, glucan is a maximum in the cell wall, accounting for 60–65% of
the total polysaccharides andmannan accounts for 20–25% [24]. The ef-
fect of the cell wall on the exertion of antifungal activity of protonectin
also was determined. Our results revealed that the incubation of
protonectin with laminarin (β-1,3-glucan) could decrease the antifun-
gal activity dramatically, indicating that protonectin could bind with
the fungal cell wall. This was further conﬁrmed by the location of
FITC-pro under the CLMS view. Then we could speculate that pro-
tonectin ﬁrst bound to the fungal cell by the peptide–laminarin inter-
action, then it passed through the cell wall and interacted with the
lipid membrane to exert its antifungal activity.
Notably, fungal infection is becoming an increasingly life-threaten-
ing medical problem not only because of the emergence of multidrug
resistant fungi but also the obstacle of fungal treatment in immunocom-
promised patients. The formation of bioﬁlm was a kind of obstacle for
treatment and always made the situation worse [23]. Bioﬁlm formation
represents the most common growth pattern of microorganisms in na-
ture, a phase that presumably resists the invasion of innate immune sys-
tem and antifungal agents [25]. The misuse of antifungal agents made
thebioﬁlmbecomesmore andmore resistant to the innate immune sys-
tem and chemotherapy [21]. Our results showed that protonectin has
the potential to be used to inhibit the formation of bioﬁlm or eliminate
the formed bioﬁlm.
Furthermore, as we know, ROS generated as a natural byproduct of
the normalmetabolismof oxygen andhad important roles in cell signal-
ing andmaintaining internal homeostasis [26]. However, under the en-
vironmental stress, ROS levels could increase dramatically, resulting in
signiﬁcant damage to cell structures. Recent studies demonstrate that
endogenous reactive oxygen species is an important mediator of anti-
fungal effect [27]. So in the present study, the effect of protonectin on
the production of ROS also was tested. Our results showed that
protonectin could induce the production of ROS in a time- and concen-
tration-dependent manner. The mitochondrion is the site of oxidative
metabolism in the cell, which is involved in the production and degra-
dation of highly reactive and toxic oxidizing agent. So protonectin
might affect the function of mitochondrion and result in the production
of oxygen radicals, which lead to the cell death. It could be concluded
that mitochondrion might be involved in the action mechanism of
protonectin.
In conclusion, as the systemic fungal infections are becoming amajor
cause of morbidity and mortality in debilitated patients, and the cur-
rently available antifungal therapies exhibit limited effectiveness and
Fig. 10. Effects of protonectin on the bioﬁlm formation of C. albicans. Cells of indicated stage were treated by protonectin at the indicated concentration for 18 h. The bioﬁlmmorphology
was assessed by phase contrast microscopy. Protonectin could inhibit the growth of adhesion-stage or intermediate-stage bioﬁlm completely at the concentration of 1–2 ×MIC.While at
the maturation phase bioﬁlm, the inhibition concentration was up to 4 × MIC. The inhibition effects were in a concentration dependent manner.
2372 K. Wang et al. / Biochimica et Biophysica Acta 1848 (2015) 2365–2373severe side effects, the search for better therapeutic strategies is in an
urgent need. Our results showed that protonectin had potent antifungal
activity, with membrane active and mitochondrion involved action
mode. Togetherwith the inhibition of the growth of bioﬁlm, protonectin
would act as a potential alternative of conventional antifungal agents.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2015.07.008.Conﬂict of interest
The authors disclose no conﬂicts.Acknowledgments
This work was supported by grants from the National Natural
Science Foundation of China (nos. 31200584, 21272108, 21432003,
91213302, 81473095); the Key National S&T Program “Major New
Drug Development” of the Ministry of Science and Technology
(2012ZX09504001-003); the Research Fund for the Doctoral Program
of Higher Education of China (20120211120045) and the Fundamental
Research Funds for the Central Universities (lzujbky-2015-155).References
[1] A.M. Algahmi, M.K. Ayyash, P. Oelkers, Phospholipid remodeling as a target for
antifungal drug development against Candida albicans, FASEB J. 27 (2013) 585.519.
[2] M. Pihet, J. Carrere, B. Cimon, D. Chabasse, L. Delhaes, F. Symoens, J.-P. Bouchara,
Occurrence and relevance of ﬁlamentous fungi in respiratory secretions of patients
with cystic ﬁbrosis—a review, Med. Mycol. 47 (2009) 387–397.
[3] S. Rossi, Australian Medicines Handbook 2006, Adelaide, Australian Medicines
Handbook, ISBN: 0-9757919-2-3, 2006.
[4] L.J. Douglas, Candida bioﬁlms and their role in infection, Trends Microbiol. 11 (2003)
30–36.
[5] E.M. Kojic, R.O. Darouiche, Candida infections of medical devices, Clin. Microbiol.
Rev. 17 (2004) 255–267.
[6] H. Jenssen, P. Hamill, R.E. Hancock, Peptide antimicrobial agents, Clin. Microbiol.
Rev. 19 (2006) 491–511.
[7] J. Fitton, A. Dell, W. Shaw, The amino acid sequence of the delta haemolysin of
Staphylococcus aureus, FEBS Lett. 115 (1980) 209–212.
[8] C. Morassutti, F. De Amicis, B. Skerlavaj, M. Zanetti, S. Marchetti, Production of a
recombinant antimicrobial peptide in transgenic plants using a modiﬁed VMA
intein expression system, FEBS Lett. 519 (2002) 141–146.
[9] H.G. Boman, D. Hultmark, Cell-free immunity in insects, Annu. Rev. Microbiol. 41
(1987) 103–126.
[10] S. Park, S.-H. Park, H.-C. Ahn, S. Kim, S.S. Kim, B.J. Lee, B.-J. Lee, Structural study of
novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata, FEBS
Lett. 507 (2001) 95–100.
[11] M. Zasloff, Antimicrobial peptides of multicellular organisms, Nature 415 (2002)
389–395.
[12] R.I. Lehrer, T. Ganz, Antimicrobial peptides in mammalian and insect host defence,
Curr. Opin. Immunol. 11 (1999) 23–27.
2373K. Wang et al. / Biochimica et Biophysica Acta 1848 (2015) 2365–2373[13] M.A. Mendes, B.M. de Souza, M.R. Marques, M.S. Palma, Structural and biological
characterization of two novel peptides from the venom of the neotropical social
wasp Agelaia pallipes pallipes, Toxicon 44 (2004) 67–74.
[14] K. Wang, W. Dang, J. Yan, R. Chen, X. Liu, W. Yan, B. Zhang, J. Xie, J. Zhang, R. Wang,
Membrane perturbation action mode and structure–activity relationships of
protonectin, a novel antimicrobial peptide from the venom of the neotropical social
wasp Agelaia pallipes pallipes, Antimicrob. Agents Chemother. 57 (2013) 4632–4639.
[15] G.B. Fields, R.L. NOBLE, Solid phase peptide synthesis utilizing 9-
ﬂuorenylmethoxycarbonyl amino acids, Int. J. Pept. Protein Res. 35 (1990) 161–214.
[16] C. Lass-Flörl, A. Mayr, S. Perkhofer, G. Hinterberger, J. Hausdorfer, C. Speth, M. Fille,
Activities of antifungal agents against yeasts and ﬁlamentous fungi: assessment ac-
cording to the methodology of the European Committee on Antimicrobial Suscepti-
bility Testing, Antimicrob. Agents Chemother. 52 (2008) 3637–3641.
[17] S.M. Mandala, R.A. Thornton, J. Milligan, M. Rosenbach, M. Garcia-Calvo, H.G. Bull, G.
Harris, G.K. Abruzzo, A.M. Flattery, C.J. Gill, Rustmicin, a potent antifungal agent,
inhibits sphingolipid synthesis at inositol phosphoceramide synthase, J. Biol.
Chem. 273 (1998) 14942–14949.
[18] W.S. Jang, J.S. Bajwa, J.N. Sun, M. Edgerton, Salivary histatin 5 internalization by
translocation, but not endocytosis, is required for fungicidal activity in Candida
albicans, Mol. Microbiol. 77 (2010) 354–370.
[19] A. Makovitzki, D. Avrahami, Y. Shai, Ultrashort antibacterial and antifungal
lipopeptides, Proc. Natl. Acad. Sci. 103 (2006) 15997–16002.[20] J.C. Koo, B. Lee, M.E. Young, S.C. Koo, J.A. Cooper, D. Baek, C.O. Lim, S.Y. Lee, D.J. Yun,
M.J. Cho, Pn-AMP1, a plant defense protein, induces actin depolarization in yeasts,
Plant Cell Physiol. 45 (2004) 1669–1680.
[21] L.R. Martinez, A. Casadevall, Speciﬁc antibody can prevent fungal bioﬁlm formation
and this effect correlates with protective efﬁcacy, Infect. Immun. 73 (2005)
6350–6362.
[22] J.P. Martínez, M.L. Gil, J.L. López-Ribot, W.L. Chafﬁn, Serologic response to cell wall
mannoproteins and proteins of Candida albicans, Clin. Microbiol. Rev. 11 (1998)
121–141.
[23] R.M. Donlan, Bioﬁlms: microbial life on surfaces, Emerg. Infect. Dis. 8 (2002)
881–890.
[24] P.A. Sullivan, C.Y. Yin, C. Molloy, M.D. Templeton, M.G. Shepherd, An analysis of the
metabolism and cell wall composition of Candida albicans during germ-tube
formation, Can. J. Microbiol. 29 (1983) 1514–1525.
[25] L. Hall-Stoodley, J.W. Costerton, P. Stoodley, Bacterial bioﬁlms: from the natural
environment to infectious diseases, Nat. Rev. Microbiol. 2 (2004) 95–108.
[26] T. Devasagayam, J. Tilak, K. Boloor, K. Sane, S.S. Ghaskadbi, R. Lele, Free radicals and
antioxidants in human health: current status and future prospects, J. Assoc.
Physicians India 52 (2004) 794–804.
[27] E.J. Helmerhorst, R.F. Troxler, F.G. Oppenheim, The human salivary peptide histatin 5
exerts its antifungal activity through the formation of reactive oxygen species, Proc.
Natl. Acad. Sci. 98 (2001) 14637–14642.
